Daniel K. Thorne, Chairman
President of Star Lake Capital, Inc. a private equity management and venture capital firm. Mr. Thorne is also Chairman of the eponymous Daniel K. Thorne Foundation supporting historic preservation and wildlife conservation worldwide. An ardent preservationist and conservationist, he currently is a Trustee of the National Trust for Historic Preservation, and serves on the board of the Wildlife Conservation Society, the Dian Fossey Gorilla Fund and Global Heritage Fund.
Since 1995 he has also been a principal shareholder and member of the Board of Directors of Hamilton Thorne Biosciences, Inc. and since 1999 a managing partner of Thacher Associates a New York firm specializing in integrity risk management for corporate and government entities. Mr. Thorne has in the past served on the boards of CCH, Inc. from 1979-1996, SLT Communications, and the Imperial Sugar Company as well as serving as Chairman of the Georgetown Steel Company, subsequently sold to the Mittal Steel Group.
Harry G McCoy , Pharm.D., President & CEO
Dr. McCoy is a former academic who has founded and run private and public Life Sciences companies for more than 20 years. Former President of Hamilton Thorne Biosciences, and Executive Chairman & President of MEDTOX Scientific (Nasdaq:MTOX) and Editek (AMEX:EDI). Currently Chairman of the North Shore Life Sciences Accelerator and Director of Attogen (an early-stage drug discovery company), the North Shore Technology Council, and the University of Minnesota College of Pharmacy Board of Advisors. Harry has achieved 24 - 40 fold returns for his investors and was also Director of AppTec, a venture-backed biopharmaceutical manufacturing firm which was purchased by WuXi PharmaTech (Nasdaq:WX) this year, which was the largest acquisition of a U.S. company by a Chinese company since Lenova purchased the IBM computer unit, forming the world's fourth largest pharmaceutical company. B.A. (Biology) UC San Diego, Pharm.D. UC San Francisco, post-doctoral fellowship University of Minnesota.
David J. Lane, Ph.D., VP of Biotech R&D
Formerly Senior Director of Development at Vysis Corporation and Director of Research at GENE-TRAK Systems. Education: B.S., State University of New York, Stony Brook, Ph.D., University of Colorado, and Post-Doctoral Fellow, National Jewish Hospital and Research Center, Division of Molecular and Cellular Biology, Denver, Colorado.